For instance, the Xin-Li formula has been shown to alleviate heart failure caused by hyperlipidemia and myocardial infarction in rats through Treg immunomodulation and inhibition of the NLRP3 inflammasome (13). Here, NLRP3 is linked to hyperlipidemia.